Advertisement

Development and testing of an HIV-risk screening instrument for use in health care settings

  • Barbara Gerbert
    Correspondence
    Address correspondence to: Barbara Gerbert, PhD, Professor and Chair, Division of Behavioral Sciences, University of California, San Francisco, 601 Montgomery, Suite 810, San Francisco, California 94111
    Affiliations
    Division of Behavioral Sciences, School of Dentistry (Gerbert, Bronstone), University of California, San Francisco, California, USA, 94111
    Search for articles by this author
  • Amy Bronstone
    Affiliations
    Division of Behavioral Sciences, School of Dentistry (Gerbert, Bronstone), University of California, San Francisco, California, USA, 94111
    Search for articles by this author
  • Stephen McPhee
    Affiliations
    Division of General Internal Medicine, Department of Medicine (McPhee, Pantilat), University of California, San Francisco, California, USA, 94111
    Search for articles by this author
  • Steven Pantilat
    Affiliations
    Division of General Internal Medicine, Department of Medicine (McPhee, Pantilat), University of California, San Francisco, California, USA, 94111

    Program in Medical Ethics, Department of Medicine (Pantilat), University of California, San Francisco, California, USA, 94111
    Search for articles by this author
  • Michael Allerton
    Affiliations
    Kaiser Permanente Medical Group, Inc., Kaiser Permanente Medical Center (Allerton), Oakland, California 94612, USA
    Search for articles by this author

      Abstract

      Objective: To develop and test a brief, reliable, and valid HIV-risk screening instrument for use in primary health care settings.
      Design: A two-phase study: (1) developing a self-administered HIV-risk screening instrument, and (2) testing it with a primary care population, including testing the effect of confidentiality on disclosure of HIV-risk behaviors.
      Setting: Phase 1: 3 types of sites (a blood donor center, a methadone clinic, and 2 STD clinics) representing low and high HIV-seroprevalence rates. Phase 2: 4 primary care sites.
      Participants: Phase 1: 293 consecutively recruited participants. Phase 2: 459 randomly recruited primary care patients.
      Main Outcome Measure: Phase 1: comparison of the responses of participants from low and high HIV-seroprevalence sites. Phase 2: primary care patients’ rates of disclosure of HIV-risk behaviors and ratings of acceptability.
      Results: Phase 1: through examining item-confirmation rates, item-total correlations, and comparison of responses from low and high HIV-seroprevalence sites, we developed a final 10-item HIV-risk Screening Instrument (HSI) with an internal consistency coefficient of .73. Phase 2: 76% of primary care patients disclosed at least 1 risky behavior and 52% disclosed 2 or more risky behaviors. Patients were willing to disclose HIV-risk behaviors even knowing that their physician would see this information. Ninety-five percent of our patient participants were comfortable with the questions on the HSI, 78% felt it was important that their doctor know their answers, and 52% wished to discuss their answers with their physician.
      Conclusion: Our brief, self-administered HSI is a reliable and valid measure. The HSI can be used in health care settings to identify individuals at risk for HIV and to initiate HIV testing, early care, and risk-reduction counseling, necessary goals for effective HIV prevention efforts.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. U.S. HIV and AIDS cases reported through December 1995. Atlanta: Centers for Disease Control and Prevention; 1995.

        • Karon J.M
        • Rosenberg P.S
        • McQuillan G
        • Khare M
        • Gwinn M
        • Petersen L.R
        Prevalence of HIV infection in the United States, 1984 to 1992.
        JAMA. 1996; 276: 126-131
        • Arno P.S
        • Shenson D
        • Siegel N.F
        • Franks P
        • Lee P.R
        Economic and policy implications of early intervention in HIV disease.
        JAMA. 1989; 262: 1493-1498
        • Hellinger F.J
        Forecasting the medical care costs of the HIV epidemic.
        Inquiry. 1991; 28: 213-225
        • Stephenson J
        New anti-HIV drugs and treatment strategies buoy AIDS researchers.
        JAMA. 1996; 275: 579-580
      2. Hammer S. Advances in antiretroviral therapy and viral load monitoring. XI International Conference on AIDS. Vancouver; 1996.

        • Wenger N.S
        • Kusseling F.S
        • Beck K
        • Shapiro M.F
        When patients first suspect and find out they are infected with the human immunodeficiency virus.
        AIDS Care. 1994; 6: 399-405
      3. New York Times. US offers guide for doctors on care of those with HIV. New York Times. New York; 1994.

        • Gerbert B
        • Bleecker T
        • Bernzweig J
        Is anybody talking to physicians about acquired immunodeficiency syndrome and sex?.
        Arch Fam Med. 1993; 2: 45-51
      4. Gerbert B, Bleecker T, McPhee S, Binson D, Catania J. Everything you always wanted to know about your patients’ sex lives … but were afraid to ask. Society for General Internal Medicine 18th Annual Meeting. San Diego, California; 1995.

        • Makadon H.J
        • Silin J.G
        Prevention of HIV infection in primary care.
        Ann Intern Med. 1995; 123: 715-719
        • Lewis C.E
        • Montgomery K
        The AIDS-related experiences and practices of primary care physicians in Los Angeles.
        Am J Public Health. 1990; 80: 1511-1513
        • Fredman L
        • Rabin D.L
        • Bowman M
        • et al.
        Primary care physicians’ assessment and prevention of HIV infection.
        Am J Prev Med. 1989; 5: 188-195
        • Gerbert B
        • Maguire B.T
        • Bleecker T
        • Coates T.J
        • McPhee S.J
        Primary care physicians and AIDS.
        JAMA. 1991; 266: 2837-2842
        • Boekeloo B.O
        • Rabin D.L
        • Coughlin S.S
        • Labbok M.H
        • Johnson J.C
        Knowledge, attitudes, and practices of obstetricians-gynecologists regarding the prevention of human immunodeficiency virus infection.
        Obstet Gynecol. 1993; 81: 131-136
        • Darke S
        • Hall W
        • Heather N
        • Ward J
        • Wodak A
        The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users.
        AIDS. 1991; 5: 181-185
        • Catania J.A
        • Gibson D.R
        • Chitwood D.D
        • Coates T.J
        Methodological problems in AIDS behavioral research.
        Psychol Bull. 1990; 108: 339-362
        • Padian N.S
        • Aral S
        • Vranizan K
        • Bolan G
        Reliability of sexual histories in heterosexual couples.
        Sex Transm Dis. 1995; 22: 169-172
        • Kauth M.R
        • St. Lawrence J.S
        • Kelly J.A
        Reliability of retrospective assessments of sexual HIV risk behavior.
        AIDS Educ Prev. 1991; 3: 207-214
        • Brody S
        Lack of evidence for transmission of human immunodeficiency virus through vaginal intercourse.
        Arch Sex Behav. 1995; 24: 383-393
        • Zenilman J.M
        • Weisman C.S
        • Rompalo A.M
        • et al.
        Condom use to prevent incident STDs.
        Sex Transm Dis. 1995; 22: 15-21
        • Doll L.S
        • Harrison J.S
        • Frey R.L
        • et al.
        Failure to disclose HIV risk among gay and bisexual men attending sexually transmitted disease clinics.
        Am J Prev Med. 1994; : 125-129
        • Catania J
        • Binson D
        • Van Der Straten A
        • Stone V
        Methodological research on sexual behavior in the AIDS era.
        Annu Rev Sex Res. 1995; 6: 77-125
        • Lazzarin A
        • Saracco A
        • Musicco M
        • Nicolosi A
        Man-to-woman sexual transmission of the human immunodeficiency virus.
        Arch Intern Med. 1991; 151: 2411-2416
        • Catania J.A
        • Binson D
        • Dolcini M.M
        • et al.
        Risk factors for HIV and other sexually transmitted diseases and prevention practices among US heterosexual adults.
        Am J Public Health. 1995; 85: 1492-1499
        • European Study Group
        Risk factors for male to female transmission of HIV.
        Br Med J. 1989; 298: 411-415
        • Padian N
        • Marquis L
        • Francis D.P
        • et al.
        Male-to-female transmission of human immunodeficiency virus.
        JAMA. 1987; 258: 788-790
        • Guimaraes M.D
        • Munoz A
        • Boschi-Pinto C
        • Castilho E.A
        HIV infection among female partners of seropositive men in Brazil.
        Am J Epidemiol. 1995; 142: 538-547
        • Ekstrand M.L
        • Coates T.J
        • Guydish J.R
        • Hauck W.W
        • Collette L
        • Hulley S.B
        Are bisexually identified men in San Francisco a common vector for spreading HIV infection to women?.
        Am J Public Health. 1994; 84: 915-919
        • Alcabes P
        • Munoz A
        • Vlahov D
        • Friedland G.H
        Incubation period of human immunodeficiency virus.
        Epidemiol Rev. 1993; 15: 303-318
        • McElrath K
        • Chitwood D.D
        • Griffin D.K
        • Comerford M
        The consistency of self-reported HIV risk behavior among injection drug users.
        Am J Public Health. 1994; 84: 1965-1970
        • MMWR
        Human immunodeficiency virus infection in the United States.
        MMWR Morb Mortal Wkly Rep. 1987; 36: 1-48
        • Baker A
        • Kochan N
        • Dixon J
        • Wodak A
        • Heather N
        HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment.
        Addiction. 1995; 90: 545-554
        • Weinstock H.S
        • Sidhu J
        • Gwinn M
        • Karon J
        • Petersen L.R
        Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988–1992.
        J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 9: 514-522
        • Corona R
        • Gentili G
        • Rezza G
        • et al.
        Prevalence of antibodies to human immunodeficiency virus type 1 and condom use among outpatients at a sexually transmitted disease clinic in Rome.
        Eur J Clin Microbiol Infect Dis. 1992; 11: 328-333
        • Rhodes T
        • Donoghoe M
        • Hunter G
        • Soteri A
        • Stimson G.V
        Sexual behaviour of drug injectors in London.
        Addiction. 1994; 89: 1085-1096
        • Watkins K.E
        • Metzger D
        • Woody G
        • McLellan A.T
        Determinants of condom use among intravenous drug users.
        AIDS. 1993; 7: 719-723
        • Choi K.H
        • Catania J.A
        Changes in multiple sexual partnerships, HIV testing, and condom use among US heterosexuals 18 to 49 years of age, 1990 and 1992.
        Am J Public Health. 1996; 86: 554-556
        • Seidman S.N
        • Rieder R.O
        A review of sexual behavior in the United States.
        Am J Psychiatry. 1994; 151: 330-341
        • Petersen L.R
        • Doll L.S
        • White C.R
        • Johnson E
        • Williams A
        Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors.
        Transfusion. 1993; 33: 552-557
        • Maheux B
        • Haley N
        • Rivard M
        • Gervais A
        STD risk assessment and risk-reduction counseling by recently trained family physicians.
        Acad Med. 1995; 70: 726-728
        • Centers for Disease Control
        HIV prevention practices of primary-care physicians.
        MMWR. 1994; 42: 988-992
        • Kassler W.J
        • Wu A.W
        Addressing HIV infection in office practice.
        Prim Care. 1992; 19: 19-33
        • Catania J.A
        • Coates T.J
        • Stall R
        • et al.
        Prevalence of AIDS-related risk factors and condom use in the United States.
        Science. 1992; 258: 1101-1106
        • Johnston K
        • Gerbert B
        • Christopher-Richards A
        • Wiener C
        Sex, lies, and the physician-patient relationship.
        J Gen Intern Med. 1996; 11S: 124